In HNSCC, its expression is negatively correlated with the number of CD8+ T cells and resting dendritic cells, suggesting that SLC2A3 may promote tumor progression by inhibiting immune cell function.200. This evidence concerns the gene SLC2A3 and head and neck squamous cell carcinoma.